There are 140 resources available
2P - Integrated analysis of DNA and RNA revealed PARPi resistant mechanism of ovarian cancer: A paired tissue analysis of pre and post PARPi therapy
Presenter: Qingli Li
Session: Poster Display
3P - The validation of a homologous recombination deficiency assay into clinical practice within the NHS
Presenter: Elizabeth Ratsma
Session: Poster Display
4P - Mutational landscape of ovarian cancer patients (pts) by homologous recombination deficiency (HRD) status
Presenter: Daniela Montanari
Session: Poster Display
5P - Ovarian cancer ESCAT gene actionability: Cinderella wears the gown
Presenter: Floriana Camarda
Session: Poster Display
6P - An innovative evidence-based laboratory medicine (EBLM) test to help doctors in the screening of ovarian cancer
Presenter: José Diego Santotoribio
Session: Poster Display
7P - Unveiling the prognostic significance of protein expression in advanced high-grade serous ovarian cancer: A comparative study between long-term survivors and early mortal patients
Presenter: Ji-Won Ryu
Session: Poster Display
8P - Biomarkers to predict chemotherapy response in low-grade serous ovarian carcinoma
Presenter: Seema Kumari
Session: Poster Display
9P - Synergistic potential of vitamin D receptor and cancer stem cells markers expression in ovarian tumors
Presenter: Ljubisa Jovanovic
Session: Poster Display
10P - Human papillomavirus integration testing and high-grade cytology improve diagnostic performance of colposcopy-guided biopsy
Presenter: Han Xie
Session: Poster Display